What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to announce and provide Amgen's unaudited financial results for the first quarter ended March 31, 2018, and its financial position as of that date. It furnishes a press release containing these details.

Why does Amgen provide non-GAAP financial measures?

Amgen uses non-GAAP financial measures, such as non-GAAP earnings per share and operating income, to provide investors with supplementary information that enhances their understanding of the company's ongoing business operations and facilitates comparisons across different periods. These measures exclude items like acquisition-related amortization, restructuring charges, and certain legal settlement costs which can be irregular and impact period-to-period comparability.

What is Free Cash Flow (FCF) and why is it included?

Free Cash Flow (FCF) is a measure of liquidity calculated by subtracting capital expenditures from operating cash flow, both determined in accordance with GAAP. Amgen includes FCF to provide investors with an additional perspective on the company's ability to generate cash from its operations after accounting for necessary investments in its business.

Where can I find the detailed reconciliation of GAAP to non-GAAP figures?

The detailed reconciliations between Amgen's non-GAAP financial measures and the most directly comparable GAAP financial measures are included in the press release that is furnished as Exhibit 99.1 to this 8-K filing.

AMGN 8-K: Earnings & Results

Summary

Amgen Inc. filed an 8-K on April 24, 2018, to report its financial results for the first quarter ended March 31, 2018. The report primarily furnished a press release detailing these results, which included both GAAP and non-GAAP financial measures. Investors should note that Amgen uses non-GAAP measures to provide a more consistent view of ongoing operations, excluding items like acquisition-related expenses, restructuring costs, and legal settlements. The company also highlighted its Free Cash Flow (FCF), a key liquidity metric. The detailed reconciliations for these non-GAAP figures are provided within the furnished press release, allowing investors to understand the adjustments made and compare performance across periods. The filing emphasizes that this information is furnished and not deemed 'filed' for certain regulatory purposes.

Key Highlights

1Amgen Inc. announced its first-quarter 2018 financial results on April 24, 2018, via an 8-K filing.
2The company provided both Generally Accepted Accounting Principles (GAAP) and non-GAAP financial results.
3Non-GAAP measures exclude acquisition-related expenses, restructuring costs, and legal settlements to offer a clearer view of ongoing operations.
4Free Cash Flow (FCF) was presented as an additional key liquidity measure.
5Reconciliations between GAAP and non-GAAP figures are available in the furnished press release (Exhibit 99.1).
6The information furnished in this 8-K is not considered 'filed' for certain SEC regulations, such as Section 18 of the Exchange Act.

AMGEN INC 8-K Report, Financial Results (Apr 24, 2018)

Summary

Key Highlights

Frequently Asked Questions